Literature DB >> 2425838

Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours.

T Oikawa, A Matsuzawa, T Iwaguchi.   

Abstract

The transplantable pregnancy-dependent mammary tumour (TPDMT-4), the related hormone-dependent (TPDMT-4EP) and autonomous (T4-0I320 and T4-0I96) subline tumours, and the mammary glands from DDD mice were compared for angiogenic activity on the rabbit cornea by tissue implantation. The TPDMT-4EP tumour was established by serially transplanting TPDMT-4 tumour fragments in oestradiol plus progesterone treated mice. The T4-0I320 and T4-0I96 tumours directly derived from the TPDMT-4 and TPDMT-4EP tumours, respectively. Angiogenic activity was graded by macroscopic and microscopic examinations into 3 classes; negative, partial and complete angiogenesis. These tumours were comparable to mammary glands in activity and induced complete angiogenesis in only 15-23% of the implants. However, when partial and complete responses were combined as positive angiogenesis, TPDMT-4, T4-0I320, TPDMT-4EP and T4-0I96 tumour implants were angiogenic in 25, 29, 42 and 54%, respectively. The T4-0I96 tumour was significantly more angiogenic than the parent tumour but this was not so for the TPDMT-4EP tumour. Spontaneous C3H mouse mammary tumours, human gliomas from nude mice, rat Walker 256 carcinomas and rabbit VX-2 tumours induced complete angiogenesis in 54, 63, 59 and 92% of the implants, respectively. The results suggest that the TPDMT-4 tumour is unique in being weakly angiogenic and able to progress toward greater autonomy with or without augmented angiogenic activity in different conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425838      PMCID: PMC2001649          DOI: 10.1038/bjc.1986.156

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice.

Authors:  K B DeOme; M J Miyamoto; R C Osborn; R C Guzman; K Lum
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

2.  Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues.

Authors:  M A Gimbrone; P M Gullino
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

Review 3.  Natural history of breast cancer. Progression from hyperplasia to neoplasia as predicted by angiogenesis.

Authors:  P M Gullino
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo.

Authors:  G Alessandri; K Raju; P M Gullino
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

5.  Angiogenesis as a marker of preneoplastic lesions of the human breast.

Authors:  S S Brem; H M Jensen; P M Gullino
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

6.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.

Authors:  J W Fett; D J Strydom; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

7.  Tumor angiogenic factor. Purification from the Walker 256 rat tumor.

Authors:  A Fenselau; S Watt; R J Mello
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

8.  Angiogenesis capacity as a diagnostic marker for human eye tumors.

Authors:  D Tapper; R Langer; A R Bellows; J Folkman
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

9.  Tumor angiogenesis factor (TAF) in cultured cells derived from central nervous system tumors in humans.

Authors:  H Matsuno
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-07       Impact factor: 1.742

10.  Formation of duct-alveolar structures and new types of tumors by a pregnancy-dependent mouse mammary tumor (TPDMT-4) in virgin mice.

Authors:  A Matsuzawa; T Kaneko; Y Ikeda; T Yamamoto
Journal:  Gan       Date:  1982-06
View more
  1 in total

Review 1.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.